Ueno, T., Masuda, N., Kamigaki, S., Morimoto, T., Akiyama, F., Kurosumi, M., . . . Toi, M. (2018). A multicenter phase II trial of neoadjuvant letrozole plus low‐dose cyclophosphamide in postmenopausal patients with estrogen receptor‐positive breast cancer (JBCRG‐07): Therapeutic efficacy and clinical implications of circulating endothelial cells. Cancer Med.
Chicago Style citaatUeno, Takayuki, et al. "A Multicenter Phase II Trial of Neoadjuvant Letrozole Plus Low‐dose Cyclophosphamide in Postmenopausal Patients With Estrogen Receptor‐positive Breast Cancer (JBCRG‐07): Therapeutic Efficacy and Clinical Implications of Circulating Endothelial Cells." Cancer Med 2018.
MLA citatieUeno, Takayuki, et al. "A Multicenter Phase II Trial of Neoadjuvant Letrozole Plus Low‐dose Cyclophosphamide in Postmenopausal Patients With Estrogen Receptor‐positive Breast Cancer (JBCRG‐07): Therapeutic Efficacy and Clinical Implications of Circulating Endothelial Cells." Cancer Med 2018.